455 related articles for article (PubMed ID: 31154402)
1. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
[TBL] [Abstract][Full Text] [Related]
2. The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates.
Leung YY; Tillett W; Orbai AM; Ogdie A; Eder L; Coates LC; Holland R; Antony A; Goel N; Mease PJ; Strand V; FitzGerald O; de Wit M; Lindsay CA; Callis Duffin K; Gladman DD
J Rheumatol Suppl; 2020 Jun; 96():46-49. PubMed ID: 32482768
[TBL] [Abstract][Full Text] [Related]
3. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
[TBL] [Abstract][Full Text] [Related]
4. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
[TBL] [Abstract][Full Text] [Related]
5. Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
Leung YY; Orbai AM; Tillett W; Ogdie A; Eder L; Goel N; Hojgaard P; Holland R; Mathew AJ; Lindsay CA; Antony A; Chau J; Christensen R; Coates LC; Mease PJ; Strand V; FitzGerald O; de Wit M; Duffin KC; Gladman DD
J Rheumatol Suppl; 2021 Jun; 97():60-63. PubMed ID: 34074670
[TBL] [Abstract][Full Text] [Related]
6. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
[TBL] [Abstract][Full Text] [Related]
7. Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Goel N; Gottlieb AB
J Rheumatol Suppl; 2020 Jun; 96():1-3. PubMed ID: 32482760
[TBL] [Abstract][Full Text] [Related]
8. Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Gottlieb AB; Goel N
J Rheumatol Suppl; 2019 Jun; 95():1-3. PubMed ID: 31154397
[TBL] [Abstract][Full Text] [Related]
9. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
Orbai AM; Mease PJ; de Wit M; Kalyoncu U; Campbell W; Tillett W; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; Gossec L; Lindsay CA; Steinkoenig I; Helliwell PS; McHugh NJ; Strand V; Ogdie A
J Rheumatol; 2016 May; 43(5):965-9. PubMed ID: 27134271
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
[TBL] [Abstract][Full Text] [Related]
11. Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.
Coates LC; FitzGerald O; Mease PJ; Gladman DD; Strand V; Goel N; Campbell I; Krueger G; McHugh NJ; Helliwell PS
J Rheumatol; 2014 Apr; 41(4):782-91. PubMed ID: 24488420
[TBL] [Abstract][Full Text] [Related]
12. Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group.
Antony A; Holland R; Mathew AJ; D'Agostino MA; Maksymowych WP; Mease PJ; Goel N; Ogdie A; Coates LC; Strand V; Christensen R; Gladman DD; Orbai AM; Leung YY; Tillett W
J Rheumatol; 2022 Jun; 49(6 Suppl 1):20-25. PubMed ID: 35169049
[TBL] [Abstract][Full Text] [Related]
13. Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.
Duarte-García A; Leung YY; Coates LC; Beaton D; Christensen R; Craig ET; de Wit M; Eder L; Fallon L; FitzGerald O; Gladman DD; Goel N; Holland R; Lindsay C; Maxwell L; Mease P; Orbai AM; Shea B; Strand V; Veale DJ; Tillett W; Ogdie A
J Rheumatol; 2019 Aug; 46(8):996-1005. PubMed ID: 30770518
[TBL] [Abstract][Full Text] [Related]
14. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
[TBL] [Abstract][Full Text] [Related]
15. Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting.
Perez-Chada LM; Merola JF; Armstrong AW; Gottlieb AB
J Rheumatol Suppl; 2019 Jun; 95():28-32. PubMed ID: 31154401
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.
Højgaard P; Klokker L; Orbai AM; Holmsted K; Bartels EM; Leung YY; Goel N; de Wit M; Gladman DD; Mease P; Dreyer L; Kristensen LE; FitzGerald O; Tillett W; Gossec L; Helliwell P; Strand V; Ogdie A; Terwee CB; Christensen R
Semin Arthritis Rheum; 2018 Apr; 47(5):654-665. PubMed ID: 29037523
[TBL] [Abstract][Full Text] [Related]
17. Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting.
Zundell MP; Woodbury MJ; Lee K; Perez-Chada LM; Armstrong AW; Strand V; Merola JF; Gottlieb AB
J Rheumatol; 2023 Nov; 50(Suppl 2):47-50. PubMed ID: 37453734
[TBL] [Abstract][Full Text] [Related]
18. Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
Orbai AM; McInnes IB; Coates LC; Husni ME; Gladman DD; Gossec L; Pricop L; Chambenoit O; Meng X; Mease PJ
J Rheumatol; 2020 Jun; 47(6):854-864. PubMed ID: 31615919
[TBL] [Abstract][Full Text] [Related]
19. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
[TBL] [Abstract][Full Text] [Related]
20. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
Leung YY; Tillett W; de Wit M; Orbai AM; Coates LC; FitzGerald O; Helliwell PS; Strand V; Mease PJ; Goel N; Christensen R; Merola JF; Lindsay CA; Ogdie A; Gossec L; Gladman DD
J Rheumatol; 2023 Nov; 50(Suppl 2):53-57. PubMed ID: 37419621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
